Cesca Therapeutics News Releases http://investors.cescatherapeutics.com/ Cesca Therapeutics News Releases en ThermoGenesis Receives Health Canada Approval of its Next-Generation AXP® II System for Cord Blood Processing http://investors.cescatherapeutics.com/news-releases/news-release-details/thermogenesis-receives-health-canada-approval-its-next Marks Second Product Approval from Health Canada This Year RANCHO CORDOVA, Calif. , June 18, 2019 /PRNewswire/ -- ThermoGenesis Corp., a wholly owned subsidiary of  Cesca Therapeutics  (Nasdaq: KOOL), and a market leader in automated cellular processing, today announced that it has received Health Tue, 18 Jun 2019 08:30:00 -0400 Cesca Therapeutics News Releases 12301 ThermoGenesis to Participate in The Orthobiologic Institute's 10th Annual PRP & Regenerative Medicine Symposium http://investors.cescatherapeutics.com/news-releases/news-release-details/thermogenesis-participate-orthobiologic-institutes-10th-annual Company to promote its PXP® cellular processing system RANCHO CORDOVA, Calif. , June 5, 2019 /PRNewswire/ -- ThermoGenesis Corp. , a wholly owned subsidiary of Cesca Therapeutics (Nasdaq: KOOL), and a market leader in automated cellular processing, today announced that it will Wed, 05 Jun 2019 08:30:00 -0400 Cesca Therapeutics News Releases 12296 Cesca Therapeutics Announces 1-for-10 Reverse Split Of Common Stock http://investors.cescatherapeutics.com/news-releases/news-release-details/cesca-therapeutics-announces-1-10-reverse-split-common-stock Trading on a Post-Split Basis is Scheduled to Begin on June 5, 2019 RANCHO CORDOVA, Calif. , June 4, 2019 /PRNewswire/ --  Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced that it has Tue, 04 Jun 2019 12:00:00 -0400 Cesca Therapeutics News Releases 12276 Cesca Therapeutics Announces First Quarter 2019 Financial Results And Provides Corporate Update http://investors.cescatherapeutics.com/news-releases/news-release-details/cesca-therapeutics-announces-first-quarter-2019-financial Conference Call to be Held Today at 1:30 p.m. PDT/4:30 p.m. EDT RANCHO CORDOVA, Calif. , May 14, 2019 /PRNewswire/ --  Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced financial and Tue, 14 May 2019 16:05:00 -0400 Cesca Therapeutics News Releases 12251 Cesca Therapeutics to Announce Financial Results for the First Quarter Ended March 31, 2019 and Host a Conference Call on May 14 http://investors.cescatherapeutics.com/news-releases/news-release-details/cesca-therapeutics-announce-financial-results-first-quarter-0 RANCHO CORDOVA, Calif. , May 7, 2019 /PRNewswire/ -- Cesca Therapeutics Inc.  (Nasdaq: KOOL), a market leader in automated cellular processing and autologous cell therapies for regenerative medicine, today announced that the Company will release its financial results for the first quarter ended Tue, 07 May 2019 08:30:00 -0400 Cesca Therapeutics News Releases 12236 ThermoGenesis Releases its Enhanced X-MINI® CD3 Selection Kit for the Research Market http://investors.cescatherapeutics.com/news-releases/news-release-details/thermogenesis-releases-its-enhanced-x-minir-cd3-selection-kit - Increased flexibility allows researchers to select CD3+ cells from a sample of whole human peripheral blood - RANCHO CORDOVA, Calif. , April 17, 2019 /PRNewswire/ -- ThermoGenesis Corp. , a wholly owned subsidiary of Cesca Therapeutics (Nasdaq: KOOL), and a market leader in automated Wed, 17 Apr 2019 08:00:00 -0400 Cesca Therapeutics News Releases 12216 ThermoGenesis AXP® II and PXP® Systems Now Registered and Available in Thailand http://investors.cescatherapeutics.com/news-releases/news-release-details/thermogenesis-axpr-ii-and-pxpr-systems-now-registered-and RANCHO CORDOVA, Calif. , April 10, 2019 /PRNewswire/ -- ThermoGenesis Corp. , a wholly owned subsidiary of Cesca Therapeutics (Nasdaq: KOOL), and a market leader in automated cellular processing and autologous cell therapies for regenerative medicine, today announced that its AXP® II System  for Wed, 10 Apr 2019 08:00:00 -0400 Cesca Therapeutics News Releases 12206 Cesca Therapeutics Announces Fiscal 2018 Year End Financial Results And Provides Corporate Update http://investors.cescatherapeutics.com/news-releases/news-release-details/cesca-therapeutics-announces-fiscal-2018-year-end-financial Conference Call to be Held Today at 1:30 p.m. PDT/4:30 p.m. EDT RANCHO CORDOVA, Calif. , March 25, 2019 /PRNewswire/ --  Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and point-of-care, autologous cell therapies for regenerative medicine, today announced Mon, 25 Mar 2019 16:05:00 -0400 Cesca Therapeutics News Releases 12186 Cesca Therapeutics To Announce Financial Results For The Fourth Quarter Ended December 31, 2018 and Host Conference Call On March 25 http://investors.cescatherapeutics.com/news-releases/news-release-details/cesca-therapeutics-announce-financial-results-fourth-quarter RANCHO CORDOVA, Calif. , March 20, 2019 /PRNewswire/ -- Cesca Therapeutics Inc.  (Nasdaq: KOOL), a market leader in automated cellular processing and autologous cell therapies for regenerative medicine, today announced that the Company will release its financial results for the fourth quarter ended Wed, 20 Mar 2019 08:00:00 -0400 Cesca Therapeutics News Releases 12176 ThermoGenesis Receives Health Canada Approval of its PXP System for Automated Processing of Bone Marrow Cells http://investors.cescatherapeutics.com/news-releases/news-release-details/thermogenesis-receives-health-canada-approval-its-pxp-system RANCHO CORDOVA, Calif. , Feb. 25, 2019 /PRNewswire/ -- ThermoGenesis Corp , a private corporation owned by Cesca Therapeutics (Nasdaq: KOOL), and a market leader in automated cellular processing and autologous cell therapies for regenerative medicine, today announced that it received Health Canada Mon, 25 Feb 2019 08:00:00 -0500 Cesca Therapeutics News Releases 12171